Epoprostenol, also known as Flolan, is a medication used to treat pulmonary arterial hypertension (PAH). This condition is characterized by high blood pressure in the arteries of the lungs, which can lead to shortness of breath, fatigue, and chest pain. Epoprostenol works by dilating the blood vessels in the lungs, allowing for improved blood flow and reducing the workload on the heart.
Patients with PAH often experience a significant improvement in their symptoms when taking epoprostenol. This medication can help increase exercise tolerance, reduce the risk of heart failure, and improve overall quality of life. It is typically administered through a continuous intravenous infusion, which requires careful monitoring and adjustment by a healthcare provider.
While epoprostenol can be highly effective in managing PAH, it is important for patients to be aware of potential side effects. These may include headache, nausea, vomiting, diarrhea, and low blood pressure. In some cases, more serious side effects such as bleeding or infection at the infusion site may occur. It is crucial for patients to communicate any concerns or changes in symptoms to their healthcare provider promptly.
As a medical professional, it is important to educate patients about the proper use and potential risks of epoprostenol. Regular monitoring of vital signs, blood tests, and echocardiograms may be necessary to ensure the medication is working effectively and safely. By working closely with patients and their healthcare team, we can help manage PAH and improve outcomes for those living with this challenging condition.
EN 
ES 
FR 
PT 
ZH